In its most recent quarter, Lam Research reported earnings per share of $1.27, beating the consensus estimate by $0.10. Revenue totaled $5.34 billion, surpassing analyst forecasts by $110 million and representing a 22.1% increase year-over-year. Net margin expanded to 30.22%, while return on equity reached 62.81%. Management set guidance for the next quarter at $1.250 to $1.450 in earnings per share and projected full-year EPS of approximately 3.71, reflecting confidence in sustained demand for its wafer fabrication equipment.

Wallace Hart LLC initiated a position of 8,671 shares valued at about $1.16 million, making Lam Research its 20th largest holding and accounting for 0.9% of the fund’s assets. Other recent entrants include IMG Wealth Management with a $26,000 stake, Howard Hughes Medical Institute with $27,000, Sound Income Strategies at $41,000, Strategic Wealth Investment Group at $29,000, and Tripletail Wealth Management at $44,000. Institutional and hedge fund ownership collectively stands at 84.61% of the outstanding shares.

Bank of America raised its price objective on Lam Research from 195 to 245 and maintains a Buy rating. JPMorgan Chase elevated its target from 165 to 300, affirming an Overweight stance. Cantor Fitzgerald increased its objective to 320, while Stifel Nicolaus boosted its target from 250 to 280, both with Buy recommendations. Overall, one analyst rates the stock as Strong Buy, 28 as Buy and seven as Hold. The consensus rating is Moderate Buy, with an average price target of 238.32.

Chief Financial Officer Douglas R. Bettinger sold 40,080 shares at an average price of 150.60, generating proceeds of approximately $6.04 million and reducing his ownership by 3.90% to 987,237 shares valued near $148.68 million. The company also declared a quarterly dividend of $0.26 per share, equivalent to $1.04 annually, representing a payout ratio of 21.31% and yielding 0.4%. Shareholders of record as of the December 3 ex-dividend date received the payment on January 7.